| Ac4ManNAz | Per-O-acetylated N-azido-acetylmannosamine; |
| AGF | Angiogenic growth factor; |
| CMAS | Cytosine 5′-monophosphate N-acetylneuraminic acid synthetase; |
| CAR-T cell | Chimeric antigen receptor T-Cell; |
| CMAH | Cytidine monophosphate N-acetylneuraminic acid hydroxylase; |
| CMP-Neu5Ac | Cytidine-5′-monophospho-N-acetylneuraminic acid; |
| EGF | Epidermal growth factor; |
| EGFR | Epidermal growth factor receptor; |
| EMT | Epithelial-mesenchymal transition; |
| ERK | Extracellular signal–regulated kinases; |
| FAK | Focal adhesion kinase; |
| Fc | The fragment crystallizable region of antibody; |
| GalNAc | N-acetylgalactosamine; |
| GNE | Hydrolyzing UDP-GlcNAc 2-epimerase/ManNAc-6-kinase; |
| HER | Human epidermal growth factor receptor; |
| HPLC | High performance liquid chromatography; |
| IgA/G/M | Immunoglobulin A/G/M; |
| ITIM | Immunoreceptor tyrosine based inhibitory motif; |
| LC-MS | Liquid chromatography–mass spectrometry; |
| LSA | Glycolipid-bound sialic acids; |
| MAL | Maackia amurensis lectin; |
| MALDI-TOF MS | Matrix-assisted laser desorption/ionization time of flight mass spectrometry; |
| ManNAc | N-acetyl-D-mannosamine; |
| MAP | Mitogen-activated protein; |
| MS | Mass spectrometry; |
| NAL | N-acetylneuraminate lyase; |
| NANP | Neu5Ac-9-phosphate phosphatase; |
| NANS | Neu5Ac 9-phosphate synthase; |
| NCAM | Neural cell adhesion molecule; |
| NEU | Neuraminidase; sialidase; acetylneuraminyl hydrolase; |
| Neu5Ac | N-acetylneuraminic acid; |
| Neu5Gc | N-glycolylneuraminic acid; |
| NK cell | Natural killer cell; |
| PD-1/PD-L1 | Programmed cell death protein 1/ligand 1; |
| PECAM | Platelet endothelial cells adhesion molecule; |
| PEP | Phosphoenolpyruvate; |
| Siglec | Sialic acid-binding immunoglobulin-like lectins; |
| SNA | Sambucus nigra lectin; |
| TMT | Tandem mass tag; |
| TSA | Total sialic acid; |
| UDP-GlcNAc | Uridine diphosphate N-acetylglucosamine; |
| VEGF | Vascular endothelial growth factor; |
| VEGFR | Vascular endothelial growth factor receptor. |